Stanford University
Showing 21,221-21,240 of 34,488 Results
-
Michitaka Nakano
Basic Life Research Scientist, Medicine - Med/Hematology
BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.
-
Ron Nakao
Librarian for Social Science Data, Economics and Political Science, Social Sciences Resource Group
BioI am responsible for purchasing Library materials and resources, such as books, journals, and data to support research and teaching in economics and political science. Contact me if you have questions about our economics, political science or social science data collections.
I am Stanford's Representative to two Social Science Data Archives, the Inter-university Consortium for Political and Social Research (ICPSR) and the Roper Center for Public Opinion Research (Roper) and can help you access their collections and resources.
I can assist you in preparing your research proposal's Data Management Plan (DMP) and can work with you to document and share your data with other researchers (http://data.stanford.edu/) and preserve it for the long-term in the Stanford Digital Repository (https://sdr.library.stanford.edu/). -
Carolyn Springer
Rosina Pierotti Professor in Italian Literature, Emerita
BioProfessor Carolyn Springer came to Stanford in 1985 after receiving a Ph.D. in Italian language and literature from Yale University. She has received fellowships and awards from the American Academy in Rome, the Andrew W. Mellon Foundation, the Harvard Center for Italian Renaissance Studies / Villa I Tatti, the Ford Foundation, and the Fulbright Foundation. Her research has focused primarily on Renaissance and nineteenth-century literature and cultural history. She has published articles and reviews in Annali d’italianistica, Boundary 2: A Journal of Postmodern Literature, Canadian Journal of Italian Studies, Forum Italicum, GRADIVA: International Journal of Literature, The International Journal of the Humanities, Italian Quarterly, The Italianist, Italica (Journal of the American Association of Italian Studies), Modern Language Studies, NEMLA Italian Studies, Quaderni d’italianistica, Renaissance Quarterly, Sixteenth Century Journal, Stanford Italian Review, Versus: Quaderni di studi semiotici, Woman’s Art Journal, The Wordsworth Circle, and Yale Italian Studies. Professor Springer’s books include The Marble Wilderness: Ruins and Representation in Italian Romanticism, 1775-1850 (Cambridge University Press, 1987; reprinted in paperback, 2010); Immagini del Novecento italiano (Macmillan, coeditors Pietro Frassica and Giovanni Pacchiano); and History and Memory in European Romanticism (special issue of Stanford Literature Review). Her latest book, Armour and Masculinity in the Italian Renaissance, appeared in 2010 with University of Toronto Press (reprinted in paperback, 2013).
-
Hiromitsu (Hiro) Nakauchi
Professor of Genetics (Stem Cell)
Current Research and Scholarly InterestsTranslation of discoveries in basic research into practical medical applications
-
Yusuke Nakauchi, MD, PhD
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioDr. Yusuke Nakauchi is a scientist specializing in stem cell biology, focusing on normal hematopoietic stem cells (HSCs), pre-leukemic HSCs, and leukemia stem cells (LSCs).
From 2005 to 2014, he trained and practiced as a clinical hematologist in Japan, where he witnessed allogeneic hematopoietic stem cell transplantation (HSCT) cure patients with otherwise fatal blood cancers—and saw many others suffer long-term complications from graft-versus-host disease (GVHD). Having saved many patients, yet lost others he could not save, he became convinced that overcoming the limitations of leukemia treatment would require a deeper understanding of both normal HSCs and the LSCs responsible for relapse.
This conviction led him to pursue basic research. In 2010, he began his PhD in the laboratory of Professor Hiromitsu Nakauchi at the University of Tokyo, where he developed allele-specific anti-HLA monoclonal antibodies as a novel therapeutic strategy for GVHD—the first work to demonstrate that anti-HLA antibodies could be used therapeutically in HLA-mismatched transplantation. This research also revealed the importance of detailed chimerism analysis for understanding early post-transplant changes in a patient's blood and HSCs, a theme he later continued at Stanford. As a graduate student, he also contributed to work on iPSC-derived T cell therapy and a large-scale single-cell study of HSC aging.
In 2014, building on this clinical and research foundation, Dr. Nakauchi joined Professor Ravindra Majeti's laboratory at Stanford University as a postdoctoral fellow. His research there centered on TET2, one of the most frequently mutated genes in acute myeloid leukemia (AML) and clonal hematopoiesis. Using CRISPR/Cas9 editing in human hematopoietic stem and progenitor cells, he developed a tractable model of TET2-mutant pre-leukemia, showing how TET2 loss reshapes epigenetic and transcriptional programs to drive clonal expansion—and how azacitidine plus vitamin C could restore normal function in TET2-mutant cells. His work now extends to antibody-based approaches to GVHD, single-cell analysis of CMML stem cells, and advanced in vivo mouse models, pursued through collaborations across and beyond Stanford.
Dr. Nakauchi's long-term goal is to bring personalized medicine to patients with AML and other blood cancers, believing that comparing normal HSCs, pre-leukemic HSCs, and LSCs at single-cell resolution is key to understanding—and ultimately preventing—leukemia. Drawing on years as a clinician who witnessed many patients lose their lives to AML, he is driven by the conviction that discoveries in stem cell biology will one day help cure and prevent the disease.
